Indomethacin increases susceptibility to injury in human gastric cells independent of PG synthesis inhibition

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 275, Issue 4 38-4, 1998, Pages

  Kokoska, Evan R ^a   Smith, Gregory S ^a   Deshpande, Yashwant ^a   Wolff, Andrew B ^a   Miller, Thomas A ^a,b  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^b School of Medicine   (United States)

Author keywords

A 23187; Adaptive cytoprotection; AGS cells; Bile salts; Calcium; Nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; BILE SALT; CALCIMYCIN; CALCIUM ION; DEOXYCHOLIC ACID; IBUPROFEN; INDOMETACIN; LACTATE DEHYDROGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN E2;

ARTICLE; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; SPECTROPHOTOMETRY; STOMACH;

EID: 0031755232     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1998.275.4.g620     Document Type: Article

References (15)

1. Abramson, S. B., and G. Weissmann. The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 32: 1-9, 1989.
2. Alvan, G., M. Orme, L. Bertilsson, R. Ekstrand, and L. Palmer. Pharmokinetics of indomethacin. Clin. Pharmacol. Ther. 18: 364-373, 1975.
3. Brooks, P. M., and R. O. Day. Nonsteroidal antiinflammatory drugs: differences and similarities. N. Engl. J. Med. 324: 17161725, 1991.
4. Chaudhury, T. K., and A. Robert. Prevention by mild irritants of gastric necrosis produced in rats by sodium taurocholate. Dig. Dis. Sci. 25: 830-836, 1980.
5. Cima, R. R., I. Cheng, M. E. Klingensmith, N. Chattopadhyay, O. Kifor, S. C. Hebert, E. M. Brown, and D. I. Soybel. Identification and functional assay of an extracellular calcium-sensing receptor in Necturus gastric mucosa. Am. J. Physiol. 273 (Gastrointest. Liver Physiol. 36): G1051-G1060, 1997.
6. Dempsey, D. T., D. W. Mercer, B. Deb, A. Sauter, and W. P. Ritchie. Adaptive cytoprotection of gastric surface epithelial cells against injury by physiologic concentrations of bile acid. Surgery 108: 348-355, 1990.
7. Duggan, D. E., A. F. Hogans, K. C. Kwan, and F. G. McMahon. The metabolism of indomethacin in man. J. Pharmacol. Exp. Ther. 181: 563-575, 1972.
8. Durbin, T., A. Tarnawski, T. G. Douglass, S. Wu, and J. Osman. Acute injury of cultured gastric cells (KATO III) by indomethacin is partly dependent on calcium but independent of prostaglandin synthesis inhibition (Abstract). Gastroenterology 100: A57, 1991.
9. Farber, J. L. The role of calcium in cell death. Life Sci. 29: 1289-1295, 1981.
10. Fries, J. F. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J. Rheumatol. 28, Suppl.: 6-10, 1991.
11. Fujiwara, Y., A. Tarnawski, K. Fujiwara, I. Thilai, T. Arakawa, and K. Kobayashi. Indomethacin inhibits proliferation of KATO III cells in basal condition and in response to EGF (Abstract). Gastroenterology 102: A621, 1993.
12. Garcia-Rodriguez, L. A., and H. Jick. Risk of upper gastrointestinal bleeding and perforation with individual non-steroidal anti-inflammatory drugs. Lancet 343: 769-772, 1994.
13. Glarborg Jorgensen, T., U. S. Weis-Fogh, H. H. Nielsen, and H. P. Olesen. Salicylate- and aspirin-induced uncoupling of oxidative-phosphorylation in mitochondria isolated from mucosal membrane of stomach. Scand. J. Clin. Lab. Invest. 36: 649-654, 1976.
14. Glarborg Jorgensen, T., U. S. Weis-Fogh, and H. P. Olesen. The influence of acetylsalicylic acid (aspirin) on gastric mucosal content of energy rich phosphate bond. Scand. J. Clin. Lab. Invest. 36: 771-777, 1976.
15. Graham, D. Y. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers. Where do we stand? Am. J. Gastroenterol. 91: 2080-2086, 1996.